Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial

Hiddo J.L. Heerspink, Janet B. McGill, Andreas L. Birkenfeld et al.|Diabetes Research and Clinical Practice|2023

Cited by 57